HS
HighVista Strategies Portfolio holdings
AUM
$388M
1-Year Est. Return
180.25%
This Fund
S&P 500
1 Year Est. Return
+180.25%
AUM
$388M
AUM Growth
-$19.7M
(-4.8%)
Holding
181
Top Buys
| 1 | +$6.38M | |
| 2 | +$5.85M | |
| 3 | +$4.05M | |
| 4 |
Pharvaris
PHVS
|
+$3.91M |
| 5 |
Stoke Therapeutics
STOK
|
+$3.47M |
Top Sells
| 1 | +$12.9M | |
| 2 | +$12.6M | |
| 3 | +$12.3M | |
| 4 |
SNDK
Sandisk
SNDK
|
+$8.63M |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$8.61M |
Sector Composition
| 1 | Healthcare | 69.79% |
| 2 | Technology | 6.85% |
| 3 | Industrials | 5.94% |
| 4 | Financials | 3.09% |
| 5 | Consumer Discretionary | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mineralys Therapeutics
MLYS
$2.32B
| $4.52M | 1.16% |
124,544
-85,285
|
|
||
|
27
Pharvaris
PHVS
$1.82B
| $4.51M | 1.16% |
+162,370
|
|
||
28
Tarsus Pharmaceuticals
TARS
$3.3B
| $4.39M | 1.13% |
53,564
+28,710
|
|
||
29
Edgewise Therapeutics
EWTX
$3.05B
| $4.25M | 1.09% |
171,137
-36,964
|
|
||
30
Ocular Therapeutix
OCUL
$2.39B
| $4.18M | 1.08% |
344,067
+237,456
|
|
||
31
Agios Pharmaceuticals
AGIO
$1.71B
| $4.02M | 1.04% |
147,662
-47,636
|
|
||
32
Amazon
AMZN
$2.24T
| $4.02M | 1.03% |
17,397
-8,996
|
|
||
33
Apellis Pharmaceuticals
APLS
$2.65B
| $3.79M | 0.98% |
150,776
+5,047
|
|
||
34
Guardant Health
GH
$12.1B
| $3.75M | 0.97% |
36,758
-27,825
|
|
||
|
35
Stoke Therapeutics
STOK
$2.1B
| $3.67M | 0.94% |
+115,539
|
|
||
|
CMPS
36
Compass Pathways
CMPS
$797M
| $3.44M | 0.89% |
+498,933
|
|
||
37
Microsoft
MSFT
$3T
| $3.16M | 0.81% |
6,537
-2,921
|
|
||
|
LBRX
38
LB Pharmaceuticals
LBRX
$602M
| $3.12M | 0.8% |
+140,107
|
|
||
39
Palisade Bio
PALI
$270M
| $3.06M | 0.79% |
+1,300,031
|
|
||
40
GH Research
GHRS
$993M
| $3.05M | 0.79% |
240,524
-1,370
|
|
||
41
argenx
ARGX
$46.8B
| $3.02M | 0.78% |
3,588
-480
|
|
||
42
Xoma
XOMA
$325M
| $3M | 0.77% |
112,917
+7,203
|
|
||
43
TransDigm Group
TDG
$74.3B
| $2.89M | 0.74% |
+2,175
|
|
||
|
RNAM
44
DELISTED
Avidity Biosciences
RNAM
| $2.89M | 0.74% |
40,020
-25,560
|
|
||
45
Amylyx Pharmaceuticals
AMLX
$1.68B
| $2.88M | 0.74% |
+238,812
|
|
||
|
BBOT
46
BridgeBio Oncology
BBOT
$806M
| $2.87M | 0.74% |
+229,263
|
|
||
47
NVIDIA
NVDA
$4.38T
| $2.65M | 0.68% |
14,220
+820
|
|
||
48
Salesforce
CRM
$184B
| $2.28M | 0.59% |
8,613
-4,272
|
|
||
49
Visa
V
$616B
| $2.21M | 0.57% |
6,291
-1,570
|
|
||
|
SEPN
50
Septerna Inc
SEPN
$1.28B
| $2.19M | 0.56% |
+78,682
|
|